Lexaria Bioscience LEXX
NASDAQ LEXX
$2.82 +0.17 (+6.42%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Finished Goods (2018 - 2019)

Updated

Lexaria Bioscience's Finished Goods was $41,415 in fiscal Q2 2019 (quarter ended Feb 28, 2019).

Analysis

Lexaria Bioscience (LEXX) Finished Goods (2018 - 2019) Analysis & Trends

At the end of FY2018 (ended Aug 31, 2018), Finished Goods at Lexaria Bioscience came in at $9,752.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lexaria Bioscience 2.58 Mn -12.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2019 41,415.00
Aug 31, 2018 9,752.00
API Access

Lexaria Bioscience Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=LEXX&period=max&api_key=YOUR_API_KEY